XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Earnings Per Share

11. EARNINGS PER SHARE

The following table sets forth the components of the denominator for the computation of basic and diluted earnings per share for net loss attributable to Community Health Systems, Inc. stockholders:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Weighted-average number of shares outstanding — basic

 

 

130,659,672

 

 

 

129,095,571

 

 

 

130,176,976

 

 

 

128,460,419

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock awards

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock options

 

 

 

 

 

 

 

 

 

 

 

 

Other equity-based awards

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares outstanding — diluted

 

 

130,659,672

 

 

 

129,095,571

 

 

 

130,176,976

 

 

 

128,460,419

 

 

The Company generated a loss attributable to Community Health Systems, Inc. stockholders for each of the three-month and six-month periods ended June 30, 2023 and 2022, so the effect of dilutive securities is not considered because their effect would be antidilutive. If the Company had generated income during the three months ended June 30, 2023 and 2022, the effect of restricted stock awards, employee stock options, and other equity-based awards on the diluted shares calculation would have been an increase of 202,182 shares and 1,152,737 shares, respectively. If the Company had generated income during the six months ended June 30, 2023 and 2022, the effect of the restricted stock awards, employee stock options, and other equity-based awards on the diluted shares calculation would have been an increase of 335,188 shares and 1,675,586 shares, respectively.

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Dilutive securities outstanding not included in the computation
   of earnings per share because their effect is antidilutive:

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock options and restricted stock awards

 

 

7,191,908

 

 

 

4,439,146

 

 

 

6,540,493

 

 

 

2,858,073